Outcomes of Therapy with Venetoclax Combined with Hypomethylating Agents in Favorable-Risk Acute Myeloid Leukemia (AML)

被引：2
|
作者：
Arslan, Shukaib
Zhang, Jianying
Dhakal, Prajwal
Moran, Jenna A.
Naidoo, Nuthana
Story, Jennifer Lombardi
Pullarkat, Vinod A.
Stein, Anthony S.
Marcucci, Guido
Yaghmour, George
Bhatt, Vijaya R.
Fathi, Amir T.
Aldoss, Ibrahim
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142780
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia
    Singh, Reema
    Halder, Rohan
    Verma, Megha
    Mehta, Pallavi
    Agrawal, Narendra
    Ahmed, Rayaz
    Bhurani, Dinesh
    BLOOD, 2022, 140 : 11713 - 11715
  • [32] Evaluating Venetoclax Treatment Duration When Combined with Hypomethylating Agents in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Uchida, Emma
    Lei, Matthew M.
    Brunner, Andrew M.
    Fathi, Amir T.
    Signorelli, Jessie
    BLOOD, 2021, 138
  • [33] Differences in Molecular Alterations and Clinical Outcomes By Ethnicity for Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax
    Zhou, Edward
    Boisclair, Stephanie
    Naing, Phyu Thin
    Thakur, Richa
    Goldberg, Bradley
    Jou, Erin
    Chitty, David W.
    Kolitz, Jonathan E.
    BLOOD, 2023, 142
  • [34] Outcomes and Predictors of Relapse with Use of Hypomethylating Agents in Combination with Venetoclax Prior to Allogeneic Transplant in Acute Myeloid Leukemia
    Nizamuddin, Imran
    Oh, Timothy Seijung
    Numan, Yazan
    Kelsten, Max Farber
    Burkart, Madelyn
    Frankfurt, Olga
    Vigil, Carlos E.
    Abaza, Yasmin
    Altman, Jessica K.
    Dinner, Shira
    BLOOD, 2021, 138
  • [35] Real World Treatment Patterns and Outcomes of Venetoclax (Ven) and Hypomethylating Agents (HMA) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States
    Vachhani, Pankit
    Abbas, Jonathan A.
    Flahavan, Evelyn M.
    Ma, Esprit
    Xu, Tao
    Jin, Huan
    Montez, Melissa
    Huang, Weize
    Gershon, Anda
    Ku, Grace
    Flores, Brannon
    Onishi, Maika
    Bui, Cat N.
    Donnellan, William
    BLOOD, 2021, 138
  • [36] Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients
    Morsia, Erika
    McCullough, Kristen
    Joshi, Maansi
    Cook, Joselle
    Alkhateeb, Hassan B.
    Al-Kali, Aref
    Begna, Kebede
    Elliott, Michelle
    Hogan, William
    Litzow, Mark
    Shah, Mithun
    Pardanani, Animesh
    Patnaik, Mrinal
    Tefferi, Ayalew
    Gangat, Naseema
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : 1511 - 1521
  • [37] Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents
    Johnson, Isla M.
    Bezerra, Evandro D.
    Farrukh, Faiqa
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun V.
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD, 2021, 138
  • [38] Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents
    Jin, Dian
    He, Jingsong
    Chen, Haoguang
    Wu, Wenjun
    Han, Xiaoyan
    Le, Jing
    Shu, Wenxiu
    Yang, Qianqian
    Pei, Shanshan
    Cai, Zhen
    He, Donghua
    CANCER MEDICINE, 2024, 13 (14):
  • [39] Outcomes Based on Sequential Use of Venetoclax Based Therapy and Targeted Therapy in Acute Myeloid Leukemia (AML)
    Stahl, Maximilian
    Shallis, Rory M.
    Derkach, Andriy
    Goldberg, Aaron D.
    Stein, Anthony
    Stein, Eytan M.
    Marcucci, Guido
    Zeidan, Amer M.
    Shimony, Shai
    DeAngelo, Daniel J.
    Stone, Richard M.
    Aldoss, Ibrahim
    Ball, Brian J.
    Bewersdorf, Jan Phillip
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S209 - S210
  • [40] Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia
    Dian Jin
    Haoguang Chen
    Jingsong He
    Yi Li
    Gaofeng Zheng
    Yang Yang
    Yi Zhao
    Jing Le
    Wenxiu Shu
    Donghua He
    Zhen Cai
    Targeted Oncology, 2024, 19 : 237 - 249
12345